Mayfair Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mayfair Advisory Group's AMGN Position: Q3 2026 in Review
Mayfair Advisory Group reduced its Amgen (AMGN) stake by 1.8% in Q3 2026, selling an estimated $7.17K and leaving 969 shares worth $408K. The position accounts for 0.12% of the portfolio, ranked #123.
Mayfair Advisory Group first reported a position in AMGN in Q3 2020 and has held it in 20 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Mayfair Advisory Group held 969 shares of Amgen worth $408K as of Q3 2026.
- Mayfair Advisory Group sold 18 Amgen shares in Q3 2026, an estimated $7.17K.
- Amgen made up 0.12% of Mayfair Advisory Group's portfolio in Q3 2026, its #123 holding.
- Mayfair Advisory Group first reported a position in Amgen in Q3 2020 and has held it in 20 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Mayfair Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.